US Patent 10273305 Bispecific CXCR4-CD4 polypeptides with potent anti-HIV activity
All edits
Edits on 9 Dec, 2023
Golden AI
Edits made to:
Article (+232 characters)
Article
Patent abstract
The present invention relates to bispecific polypeptides that are directed against the cellular receptor CD4 as well as a cellular co-receptor for HIV. Said polypeptides may be used to prevent human cell entry of HIV.
Edits on 2 Oct, 2023
Golden AI
Edits made to:
Infobox (+5 properties)
Infobox
Patent Inventor Names
Catelijne Stortelers0
Dominique Schols0
Hugo Soares0
Peter Vanlandschoot0
Philippe Van Rompaey0
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 30 Apr, 2023
Golden AI
Infobox
Patent Citations Received
Edits on 22 Mar, 2023
Golden AI
Infobox
Patent Citations Received
Edits on 28 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
102733050
Date of Patent
April 30, 2019
0Patent Application Number
155624370
Date Filed
April 1, 2016
0Official Website
Patent Citations Received
Patent Primary Examiner
Edits on 25 Sep, 2022
Golden AI
Infobox
Patent Citations Received
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 19 May, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
Edits on 12 Feb, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
Edits on 26 Jan, 2022
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 10273305 Bispecific CXCR4-CD4 polypeptides with potent anti-HIV activity
Infobox
Is a
Patent jurisdiction
Patent number
10273305
Date of patent
April 30, 2019
Patent application number
15562437
Date Filed
April 1, 2016
Patent primary examiner
Find more entities like US Patent 10273305 Bispecific CXCR4-CD4 polypeptides with potent anti-HIV activity
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
